Drug
Qvm149
Qvm149: highest development phase Phase 3, developed by Novartis. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| QVM149 NCT04206761 | Phase 3 | Asthma |
| QVM149 NCT05776927 | Phase 3 | Asthma |
Latest
No recent events.
Follow Qvm149 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.